The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study

Background and Objectives: The present study aims to analyze the complex patient/treating physician interaction at onset of botulinum toxin (BoNT) therapy in patients with idiopathic cervical dystonia (CD) and the influence of high initial doses on long-term outcomes. Materials and Methods: A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefter, Harald, Schomaecker, Isabelle, Schomaecker, Max, Rosenthal, Dietmar, Samadzadeh, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779899/
https://www.ncbi.nlm.nih.gov/pubmed/35056396
http://dx.doi.org/10.3390/medicina58010088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779899/
https://www.ncbi.nlm.nih.gov/pubmed/35056396
http://dx.doi.org/10.3390/medicina58010088

Ejemplares similares